Tocilizumab: blockade of interleukin-6 signaling pathway as a therapeutic strategy for inflammatory disorders.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/DAC9FD6F.svg?ark=w1%2F20260515%2FDAC9FD6F)](https://nobleid.org/work/w1/20260515/DAC9FD6F)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors